CCL21: A Protein Involved in Cell Death, Signaling and Ion Channels

Target Name: CCL21

NCBI ID: G6366

CCL21

CCL21: A Protein Involved in Cell Death, Signaling and Ion Channels

CCL21, also known as CKb9, is a protein that is expressed in various tissues throughout the body. It is a member of the kilhong protein family, which is a group of transmembrane proteins that play a significant role in intracellular signaling. One of the The most significant functions of CCL21 is its role in the regulation of cell death, which is critical for the maintenance of tissue homeostasis and the development and maintenance of various physiological processes.

CCL21 is a 21-kDa protein that is expressed in a variety of tissues, including the brain, heart, liver, and kidneys. It is highly conserved across different species, which indicates that it has an important role in the evolution of early metazoa. CCL21 is also known to be involved in several cellular processes, including cell adhesion, migration, and the regulation of ion channels.

One of the most significant functions of CCL21 is its role in cell death. CCL21 has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. During apoptosis, CCL21 helps to promote the formation of apoptotic bodies, which are organelles that are involved in the programmed cell death process. Additionally, CCL21 has been shown to interact with several proteins that are involved in cell death, including Bax and p53.

Another function of CCL21 is its role in cell signaling. CCL21 is a member of the kilhong protein family, which is a group of transmembrane proteins that play a significant role in intracellular signaling. CCL21 is involved in several signaling pathways, including the TGF- 尾 pathway and the Wnt pathway. TGF-β is a well-known signaling pathway that is involved in the regulation of cell growth, differentiation, and tissue repair. differentiation, and is closely associated with the development and maintenance of tissues.

CCL21 has also been shown to play a role in the regulation of ion channels. Ion channels are critical for the regulation of various physiological processes, including muscle contractions and nerve function. CCL21 is involved in the regulation of ion channels in several ways. First, Second, it is a protein that is involved in the regulation of the ion channels that are involved in neurotransmitter release. Second, it is a protein that is involved in the regulation of the ion channels that are involved in muscle contractions. Finally, CCL21 is a protein that is involved in the regulation of the ion channels that are involved in the regulation of the water and electrolyte balance in the body.

In conclusion, CCL21 is a protein that is involved in several cellular processes that are critical for the maintenance of tissue homeostasis and the development and maintenance of various physiological processes. Its role in cell death, cell signaling, and ion channels regulation makes CCL21 an attractive drug target or biomarker. Further research is needed to fully understand the functions of CCL21 and its potential as a drug.

Protein Name: C-C Motif Chemokine Ligand 21

Functions: Inhibits hemopoiesis and stimulates chemotaxis. Chemotactic in vitro for thymocytes and activated T-cells, but not for B-cells, macrophages, or neutrophils. Shows preferential activity towards naive T-cells. May play a role in mediating homing of lymphocytes to secondary lymphoid organs. Binds to atypical chemokine receptor ACKR4 and mediates the recruitment of beta-arrestin (ARRB1/2) to ACKR4

The "CCL21 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCL21 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets